Back to Search Start Over

Reversible Leukoencephalopathy in a Man with Childhood-onset Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome.

Authors :
Hoshino Y
Kodaira M
Matsuno A
Kaneko T
Fukuyama T
Takano K
Yazaki M
Sekijima Y
Source :
Internal medicine (Tokyo, Japan) [Intern Med] 2022 Feb 15; Vol. 61 (4), pp. 553-557. Date of Electronic Publication: 2021 Aug 24.
Publication Year :
2022

Abstract

A 49-year-old Japanese man had shown developmental delay, learning difficulties, epilepsy, and slowly progressive gait disturbance in elementary school. At 46 years old, he experienced repeated drowsiness with or without generalized convulsions, and hyperammonemia was detected. Brain magnetic resonance imaging detected multiple cerebral white matter lesions. An electroencephalogram showed diffuse slow basic activities with 2- to 3-Hz δ waves. Genetic tests confirmed a diagnosis of hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome. Leukoencephalopathy was resolved following the administration of L-arginine and lactulose with a decrease in plasma ammonia levels and glutamine-glutamate peak on magnetic resonance spectroscopy. Leukoencephalopathy in HHH syndrome may be reversible with the resolution of hyperammonemia-induced glutamine toxicity.

Details

Language :
English
ISSN :
1349-7235
Volume :
61
Issue :
4
Database :
MEDLINE
Journal :
Internal medicine (Tokyo, Japan)
Publication Type :
Academic Journal
Accession number :
34433721
Full Text :
https://doi.org/10.2169/internalmedicine.7843-21